Skip To Main Content
Barry Bazian on Muck Rack

Barry Bazian

As seen in: Law360, JD Supra, Mondaq, Goodwin
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Barry

Contact Barry, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Goodwin Guides Royalty Pharma on $500 Million R&D Funding Collaboration for Chronic Immune-Mediated Diseases

|
By Barry Bazian
| Goodwin
The Life Sciences team advised Royalty Pharma plc (Nasdaq: RPRX) on a research and development (R&D) co-funding agreement with Johnson & Johnson for a total of $500 million in 2026 and 2027 to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases.
Open in Who Shared Issue with article?

Goodwin Advises Quotient Therapeutics on Collaboration With Merck for Up to $2.2 Billion in Total

|
By Barry Bazian
| Goodwin
The Life Sciences team advised Quotient Therapeutics on entering a multi-year research collaboration agreement with Merck to discover novel drug targets in inflammatory bowel disease (IBD) using Quotient’s somatic genomics platform technology. Under the terms of the agreement, Quotient will receive an upfront payment of $20 million. Quotient is also eligible to receive development, regulatory, and commercial milestones for a potential total deal value of up to $2.2 billion.
Open in Who Shared Issue with article?

Six Considerations For Directors Navigating Distressed M&A

|
By Barry Bazian, Michael Goldstein, Debora Hoehne, Howard Steel
| Mondaq
When a company faces financial distress or insolvency, its board of directors faces heightened scrutiny. Actions taken during this critical period are more likely to be second-guessed in hindsight by creditors, shareholders, and courts. Observing proper fiduciary duties and following appropriate governance processes are particularly important in distressed M&A transactions.
Open in Who Shared Issue with article?
See all 9 articles